A REVIEW OF THE RELATIONSHIP BETWEEN LEG POWER AND CHRONIC DESEASE IN OLDER ADULTS by Sara Elizabeth Strollo BS, Virginia Polytechnic Institute and State University, 2011 Submitted to the Graduate Faculty of the Department of Epidemiology Graduate School of Public Health in partial fulfillment of the requirements for the degree of Master of Public Health University of Pittsburgh 2013 i UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH This essay is submitted by Sara Strollo on April 18, 2013 and approved by Essay Advisor: Elsa S. Strotmeyer, PhD, MPH Assistant Professor Department of Epidemiology Graduate School of Public Health University of Pittsburgh _________________________________ Committee Member: Nancy W. Glynn, PhD ________________________________ Research Assistant Professor of Epidemiology Director, Master’s Degree Programs Department of Epidemiology Graduate School of Public Health University of Pittsburgh Committee Member: Bret H. Goodpaster, PhD _________________________________ Associate Professor of Medicine Assistant Professor of Health and Physical Education Department of Endocrinology Department of Health and Physical Education School of Medicine School of Education University of Pittsburgh ii Copyright © by Sara Strollo 2013 iii Elsa S. Strotmeyer, PhD, MPH A REVIEW OF THE RELATIONSHIP BETWEEN LEG POWER AND CHRONIC DISEASE IN OLDER ADULTS Sara Strollo, MPH University of Pittsburgh, 2013 ABSTRACT Increased life expectancy in developed countries has heightened the importance of preventing disability and preserving physical function in older adults. Lower-extremity muscle power is a relatively novel, but reliable predictor of physical function in older populations. Leg power has been shown to decline earlier than muscle strength with aging. Therefore, leg power measurements may provide earlier predictors of decreased functionality. Most leg power studies exclude participants with acute or severe chronic conditions. However, chronic diseases are prevalent among adults aged 65 years or older and should be considered when assessing muscle function of aging individuals. This master’s essay reviews the existing literature on the relationship between leg power and chronic disease in older adults. Various leg power measures and the age-associated chronic conditions of osteoarthritis, diabetes mellitus, and cardiovascular disease are assessed to characterize associations and determine gaps in the literature. Identifying future priorities of research, aimed to improve late life independence among older adults, is of high public health importance. This review emphasizes the important role of prevalent age-associated chronic conditions when assessing lower-extremity muscle power and physical function in older adults. iv TABLE OF CONTENTS PREFACE .................................................................................................................................................. vi 1.0 INTRODUCTION ............................................................................................................................1 2.0 LEG POWER ....................................................................................................................................3 3.0 4.0 2.1 KEISER PNEUMATIC LEG PRESS ........................................................................................... 4 2.2 NOTTINGHAM POWER RIG .................................................................................................... 5 2.3 SIT-TO-STAND MOVEMENT ................................................................................................... 7 2.4 COUNTERMOVEMENT JUMP .................................................................................................. 8 2.5 STANDARD MEASURE OF LEG POWER.............................................................................10 CHRONIC DISEASE..................................................................................................................... 11 3.1 OSTEOARTHRTIS.....................................................................................................................13 3.2 DIABETES MELLITUS..............................................................................................................16 3.3 CARDIOVASCULAR DISEASE ................................................................................................20 CONCLUSION ............................................................................................................................... 25 BIBLIOGRAPHY .................................................................................................................................... 27 v PREFACE I would like to express my appreciation to my faculty advisor, Dr. Elsa Strotmeyer, for her assistance with this literature review and the opportunity to gain field experience in administering various lower-extremity power measurements. I would also like to thank Dr. Nancy Glynn and Dr. Bret Goodpaster for serving on my master’s essay committee. Their willingness to assist me with this endeavor largely contributed to its success and timely completion. vi 1.0 INTRODUCTION In the 21st century, the United States (US) and other developed countries are experiencing changing demographics with a rapid increase in adults age 65 years or older1, 2. Increased life expectancy has impacted the health care system3 and intensified the demand for medical services4. As a result, an emphasis has been placed on age-associated disability prevention and the preservation of physical function among older adults5-7. Healthy aging enables older adults to retain functional independence and a higher quality of life. Research aimed to improve late life independence has considered muscle power and chronic disease among older adults as important determinants of disability and physical function decline8. However, the relationship between chronic disease and leg power in older adults has yet to be comprehensively characterized. Muscle power, an indication of the ability to exert force quickly, is a relatively novel research measure for predicting late-life disability8-10. Muscle power is used for most habitual daily activities11. It has been shown that aging adults experience muscle power decline earlier than muscle strength12-15. Therefore, leg power measurements may provide earlier predictors of decreased functionality. Various measures of leg power have been used throughout research. Traditional measures include leg extension machines such as the Keiser leg press and Nottingham power rig. Task-based leg power measures have emerged in recent years. They are commonly performed on a force plate and include sit-to-stand and jumping movements. 1 Chronic diseases have been found to be essential underlying causes of physical disability in older adults16. They have a strong influence on middle-aged adults making a healthy transition into old age17. In addition to physical activity reduction contributing to significant impairments in function, chronic illnesses diminish quality of life and predispose individuals to disability18. Although leg power has been established as a reliable predictor of physical function among older adults, few leg power studies have assessed the relationship between muscle power and prevalent chronic diseases. Muscle power studies often exclude acute or chronic illnesses and focus on healthy participants or mobility-limited community-dwelling older adults. Therefore, conclusions often have limited generalizability to the large proportion of older adults with one or more acute or chronic illnesses. Studies that include participants with prevalent age-associated chronic diseases such as osteoarthritis (OA), diabetes mellitus (DM), and cardiovascular disease (CVD), often lack analysis of the diseases’ associations with leg power. Most merely provide the percentages of individuals with comorbidities. OA, DM, and CVD are known to contribute to physical function limitations in older adults18. A comprehensive review of the literature can identify future research directions for investigating leg power as a predictor of age-associated disability and physical function. In addition, further research in this area will provide opportunity to identify public health priorities in aging and the influences of age-associated prevalent chronic diseases. 2 2.0 LEG POWER Impairments of muscle power and lower-extremity muscle power’s relationship with physical function have gained attention in recent years8, 19-21. While muscle strength indicates a person’s ability to exert maximal muscular force, muscle power indicates the ability to exert force quickly (Power= Force x Velocity)22. Muscle power and muscle strength decrease as adults age and predict physical limitations23, 24. However, decreases in muscle power occur to a greater extent than muscle strength with aging12, 15, 25, 26 . In addition, a stronger association exists between muscle power and certain physical performances measures, such as habitual gait speed and stair climb time22, 27. Age-associated alterations in muscle power are related to a reduction in muscle mass, which is mediated by the loss of type II fast twitch fibers28, 29. Type II fibers are capable of producing four times the amount of peak power output of type I fibers30. Therefore, the loss of type II fibers are believed to be associated with advanced aging and result in muscle power impairments27, 31. Substantial loss of nerve function is quite common in older adults (25%)32 and related to leg press power33 and physical performance34 35, 36 . As a result of slower nerve conduction velocity, peak force development may be delayed and result in lower power production37. Jozsi et al. (1999) have attributed many age-associated changes in skeletal muscle to sedentary lifestyles, injury, or disease19. Each standard deviation increase in knee extensor power 3 has been associated with a reduction of disability likelihood by 27-42% (P< 0.004)38. In addition, research has shown leg power to be predictive of self-reported disability among community dwelling older women23. In general, studies have revealed elderly men to have higher muscle power levels than women12, 26, 39. Commonly used traditional leg power measures include leg presses (Keiser pneumatic), power rigs (Nottingham, Bassey), and dynamometers. These measures are often performed in seated positions and involve high velocity extensions of one or two legs at low resistances to determine power. Additional novel task-based leg power tests were designed to mirror daily mobility tasks40. Sit-to-stand movements41 and standing jumps14 are the most frequently used task-based measurements and can be performed at home or other alternative non-clinic locations without expensive equipment21, 42. Although the Keiser pneumatic leg press, Nottingham power rig, sit-to-stand movement, and countermovement jump all measure lower extremity leg power, differences exist between protocols and measurement movements. Each testing method’s strengths and weaknesses differ based on participant characteristics and study objectives43. 2.1 KEISER PNEUMATIC LEG PRESS Keiser pneumatic resistance machines are frequently used to assess lower-extremity power measurements of older adults. The Keiser pneumatic leg press is a computerized machine that measures the amount of force a participant can exert21. Force is applied through air resistance and can be easily altered between leg extensions. Prior to conducting measurements, a participant fully extends one or both legs with no load to determine a full range of motion (ROM)21, 44. The ROM begins with leg(s) at a 90-degree angle and the participant’s arms crossed 4 over their chest. Participants proceed to straighten their leg(s) against the foot plate until full extension is reached then gently return to the starting position over a period of 2, 1, and 2 seconds, respectively21. A one-repetition maximum measurement (1-RM) must be obtained prior to assessing leg power42. The 1-RM is achieved by progressively increasing the resistance between each repetition until the participant can no longer extend their leg through the full ROM21. Participants are given a 30- to 45-second rest between maximal effort repetitions21. After identifying a participant’s 1-RM, lesser intensities of the maximal force (from 40% up to 90%) are performed as fast as possible through the full ROM to determine power42. Peak power is recorded based on the highest mean power produced throughout the trials45. Generally, peak lower extremity muscle power is acquired at 70-75% of the 1-RM21, 22. The Keiser pneumatic leg press has been described and validated with excellent reliability in older adults23, 46-48. The simple control panel and computer program allows for quick and efficient measurements. In comparison to weighted machines, air-pressure resistance allows for a smooth and consistent movement that may prevent injuries49. It is the most frequently used leg power measurement in populations that assess chronic disease, especially OA37, 45, 50-52 . However, obtaining 1-RM measurements can be challenging in older adults with disability and comorbidities associated with chronic pain. Older adults may have difficulty getting in and out of the seat. Although it is easy to administer, this measurement technique is limited because the equipment is not portable, has a high cost42, and a long length of test time. 2.2 NOTTINGHAM POWER RIG The Nottingham power rig is a reproducible and validated measure of leg extension power53, 54. It has been become a popular leg power measure since it was commissioned for use in a National 5 Fitness Survey in 199055. The power rig involves a seated leg extension movement while the participant’s arms are folded over his or her chest53, 56. A flywheel that is accelerated by the participant pushing a single foot against a footplate is used to measure average power from the final velocity53. A maximum of nine trials are performed; however, testing is often stopped once five successful trials are completed53. The two highest measures should be within 5% of each other53. Bassey et al. (1992) found that leg power, measured with the Nottingham power rig, was correlated (p<0.001) with the functional measures of gait speed (r=0.80), chair-rise time (r=0. 65), and stair-climb time (r=0.81)26. The Nottingham power rig is a preferable measure for the elderly because it requires less balance than other measurements, such as jumping, stair climbing, and walking26, 53, 54, 57, 58. The equipment has been found safe and acceptable for all age groups and levels of physical capability41, 53 . In addition, the machine’s seat is suitable for individuals with back problems26, 27, 54, 57, 58. The Nottingham power rig is the most frequently used measure when assessing leg power in older adults with CVD59-62 and has been considered the “gold standard” for measuring power41, 53. Caserotti et al. (2008) concluded that explosivetype heavy-resistance training with the Nottingham power rig can even be safe and acceptable in healthy 80 to 89-year-old women14. However, the Nottingham power rig has not been used to measure leg power among older adults with OA. Disability and comorbidities associated with chronic diseases, such as OA, may interfere with obtaining leg power measurements. In addition, the equipment is expensive, lacks portability, and can be difficult to administer. 6 2.3 SIT-TO-STAND MOVEMENT Also known as a chair rise movement, the sit-to-stand movement involves the use of complex motor acts63 through the collaboration of muscle actions at both the hips and knees64. The sit-tostand movement is an essential daily movement and relevant predictor of an elderly person’s ability to live independently65. Individuals must be capable of producing enough strength and power to raise their body’s center of mass to perform this measure65. To assess leg power, the movement can be performed on a platform that measures the ground reaction of the feet41, 63, 65, 66 . Participants cross their arms over their chest while sitting on an armless, backless chair67. The chair is attached to a force platform, and the chair height is determined by the height of the participant’s lateral knee joint67. Legs are positioned at approximately a 90° angle with feet centered on the force plate and eyes fixed straight ahead66. Participants are instructed to rise as fast as possible into an upright position41, 65, 66. At least 3 trials, with resting breaks in between, are conducted to achieve a maximal power measurement67. Power is calculated from the vertical ground reaction force of body weight, the time it takes to stand upright, and body height changes during the sit-to-stand transfer41, 65. The sit-to-stand transfer is a functional task-based measure41 that older adults face on a daily basis68. Lindemann et al. (2003) suggest that using this leg power measure, instead of the Nottingham power rig, is sensible, portable and low cost41. However, power measuring force plates are large and heavy to transport. Sit-to-stand leg power measures can conveniently be performed on the same platform as the countermovement jump measurements. Thus far, this method has not been commonly used to evaluate leg power among older adults with chronic disease. However, Kuh et al. (2005) measured functional leg power by assessing chair-rise time with a stopwatch in a cohort of 53-year-old British men and women69. Participants rose from a 7 seated position into a standing position with their back and legs straightened69, 70. The movement was completed in the seated position and was performed for 10 complete trials to obtain a minimum time69, 70 . Participants with physical limitations such as balance impairments and bodily pain may have difficulty performing this measure71. The test is quick and easily administered in a clinical setting among able participants. 2.4 COUNTERMOVEMENT JUMP A countermovement jump is a vertical jump performed on a force platform to estimate maximal muscle power output14, 39, 72. Vertical velocity is calculated in conjunction with the vertical force expended to push both feet from the platform72. It is a multi-joint movement and closely related to functional performance73. Participants begin in an upright standing position and perform a fast and fluid downward preparatory knee movement (to approximately 90°) prior to pushing vertically off of the platform25, 72-74. Participants are instructed to jump as high as they can and land gently on the platform73. At least 3 maximal jumps are performed, rests occur in between jumps, and the highest jump is selected for analysis 25, 72-74. In addition to an estimation of muscle power output, the jumping movement can represent functional capability72. The majority of daily human tasks are weight-bearing and incorporate similar accelerations and decelerations of body mass72. Assessing jumping power has potential advantages in comparison to other methods of leg power measurement75. The movement only involves the same intrinsic resistance that the participant encounters on a daily basis rather than exerting muscle power against an eternal resistance75. Although the 8 countermovement jump may result in higher mechanical outcome variability than single joint tests, reproducibility has been relatively high in studies (r≥0.95)73, 76 . In addition, maximal vertical jump tests have been assessed in numerous studies among older adults without methodological issues39, 73, 76-79. A study by Runge et al. (2004) compared age effects on muscle power output among men (N=89, 18-79 years) and women (N=169, 20-88 years) of different age groups. Muscle power was assessed by countermovement jumps and chair rises. Jumping peak power specific to body mass was estimated to be lower by more than 50% in women (r=0.81 p<0.001) and men (r=0.86, p<0.001) between the ages of 20 and 80 years75. In addition to a continuous and linear muscle power decline across the age range, frail, older persons who were incapable of performing the chair-rising movements were able to complete the jumping mechanography75. Therefore, these observations may suggest that countermovement jumps are preferable for muscle power assessments in comparison to chair rises75. The countermovement jump has yet to evaluate leg power differences among older adults with common chronic conditions such as OA, DM, or CVD. However, the countermovement jump has a shorter test time than most leg power measurements and can be performed on the same platform as the sit-to-stand movement. Safety precautions, such as using a stabilization harness or additional staff members as spotters, must be considered when conducting jumping measurements among elderly participants41. 9 2.5 STANDARD MEASURE OF LEG POWER Future research could benefit from the identification of a simple, standard measurement of lower-extremity muscle power66. Authors of current literature infrequently address the strengths and weaknesses of specific leg power measurement techniques. Cost and ease of administration are essential components of studies in older adults. Although fewer studies utilize task-based leg power tests, the measures may be less expensive and burdensome than traditional leg power measures. Force platforms avoid uncomfortable seated positions and utilize daily functional movements. Future research should determine the feasibility of using task-based tests to assess leg power among older adults with chronic disease. 10 3.0 CHRONIC DISEASE As life expectancy increases throughout the US, so does the prevalence of age-related chronic health conditions37, 80, 81. A higher proportion of older adults18, 82 is accompanied with increased disability, reduced quality of life (QOL), and heightened costs of health care and long-term care18. Approximately 80% of older Americans are living with at least one chronic condition, and 50% are living with at least two2. Women tend to live longer than men in a disabled state23, 83. According to the American Heart Association, 70.2% of men and 70.9% of women between 6079 years old have CVD84. OA affects 33.6% of individuals age 65 years and older, and women tend to have higher rates of OA than men in late life85. Symptomatic knee OA affects 13.6% of women and 10.0% of men age 60 years or older86. Among individuals age 20 years or older, 11.8% of men and 10.8% of women have DM87. DM has a dramatically higher prevalence among men and individuals age 65 years or older (26.9%)87. Consequences of living with chronic illness in late life may include limitations of daily activities, loss of function, and pain88. In addition to health concerns, the prevalence of chronic conditions and the number of Americans age 65 years or older is negatively impacting the United State’s health care system37. As a result, chronic diseases consist of 95% of older Americans’ health care expenditures89. Frailty, has been considered a synonymous term for disability, comorbidity, and other physical limitations90. Fried et al. (2001) used data from the Cardiovascular Health Study (n= 5417) and found frail (n=368) men and women ≥ 65 years have significantly higher rates of 11 CVD, DM, and OA than those who were not frail or intermediately frail90. The significant associations with comorbid chronic disease included arthritis (70.6% prevalence, p<0.001), DM (25.0% prevalence, p<0.001), myocardial infarction (13.3% prevalence, p<0.001), angina (28.8% prevalence, p<0.001), congestive heart failure (13.6% prevalence, p<0.001), peripheral vascular disease (3.8% prevalence, p<0.001), and hypertension (50.8% prevalence, p<0.001)90. Arthritis, CVD, and DM are among the five most common chronic illnesses in older people88 and are known causes of disability and hospitalization among seniors91, 92 . Strength measurements can have limitations when performed on older adults with chronic conditions and their associated comorbidities. Symptomatic OA can result in chronic pain, muscle weakness, limited range of motion of the joints, and inhibited daily activities93. According to the Centers for Disease Control and Prevention (2005), approximately 60-70% of diabetic men and women have mild to severe forms of nervous system diseases such as peripheral neuropathy (PN)94. PN can further limit strength testing abilities95. Additionally, muscle weakness and physical function impairments are associated with DM95. Reduced aerobic endurance, changes in body composition, bone loss, skeletal muscle atrophy, and weakness commonly occur with declining cardiovascular status as well18. In contrast to the high resistance required to evaluate muscle strength, leg power tests are capable of assessing muscle capabilities at low resistances with high velocity movements. Although the relationships between OA, CM, CVD and leg power have yet to be comprehensively delineated, the literature occasionally addresses the influence of chronic illness. The associations between the burden of OA, DM, and CVD on leg power are particularly important to describe since these are relatively preventable conditions96-98. 12 3.1 OSTEOARTHRTIS Arthritis and similar arthritic illnesses are the leading causes of disability in the US99. As the most prevalent chronic condition among older adults, OA affects over half of all individuals over the age of 6518, 93. The incidence is known to increase with age100, and symptomatic knee OA occurs at the rate of 240 per 100,000 person years101. Osteoarthritis is an incurable chronic condition102 with various medical and disablement comorbidities. Muscle strength is commonly studied as an indicator of late-life disability among older adults. However, pain and joint stiffness as a result of disease may inhibit testing, limit compliance, cause adverse events, and result in deviations in protocols. Muscle power may be a more feasible form of measurement because it involves moving less resistance. In addition, leg power measurements have been used safely in mobility-limited older adults and persons 80 years and older103. Although hand osteoarthritis is frequently considered in muscle power studies, lower-extremity osteoarthritis has yet to be well studied23, 56. Clark et al. (2010) collected self-reports of knee osteoarthritis while comparing leg extension torque and power with a Cybex-II dynamometer104. Participants (N=89) were recruited to fulfill three specific groups: healthy middle-aged adults (MH, N=29, 40-55 years, mean age ± SD= 47.2 ± 4.7 years), healthy older adults (OH, N=28, 70-85 years, mean age ± SD= 74.0 ± 3.6 years), and mobility-limited older adults (OML, N=32, 70-85 years, mean age ± SD= 78.1 ± 4.5 years)104. The Short Physical Performance Battery (SPPB) was used to classify the older adults into their respective healthy or mobility-limited categories. Older adults ranking ≤ 9 (out of 12 points) on the SPPB were classified as mobility-limited. In this population, prevalence of selfreported knee OA was 0% among middle-aged adults, 7% among older adults, and 16% among mobility-limited older adults104. OA was not adjusted for in the analysis. Impaired power in the 13 older mobility-limited adult age group was shown once leg extensions were performed above 60 degrees (p<0.0001)104. The greatest leg power differences occurred at 240 degrees-second, at approximately MH=275 W, OH=200 W, and OML=100 W104. Clark et al. (2010) suggest future investigation of the potential neural mechanisms and how the neuromuscular system contributes to declines in mobility function104. In addition, further consideration of OA in the analysis may provide insight on the relationship with physical function and muscle power measurements across the various groups. Measuring lower-extremity muscle power of participants with OA may assist in determining the most feasible measuring technique, how the disease affects muscle power measurements, and whether poor results and conclusions are related to the burden of disease. De Vos et al. (2005) considered osteoarthritis prevalence as an adverse event when conducting a randomized controlled trial of resistance training programs for 8-12 weeks45. Of the 112 healthy older adults (mean age ± SD= 69 ± 6 years) evaluated with a Keiser leg press, 20 adverse events were reported among 17 participants. The rate of adverse events related to power training (0.25%) were less than strength training (0.34%). Exacerbation of OA accounted for 15% of all adverse events45. All events were resolved with alterations in regimens, antiinflammatory medication, or analgesic medication45. However, adverse events related to OA may decrease with lower resistance muscle power training in comparison to strength training. In a study by Orr et al. (2006), 38 type 2 diabetic patients were randomized into a 4month tai chi (mean age ± SD= 65.9 ± 7.4 years) and sham exercise (mean age ± SD= 64.9 ± 8.1 years) controlled trial to determine associations with muscle power50. Peak muscle power was measured using a Keiser pneumatic leg press. Throughout the entire population, OA (84%) and hypertension (76%) were prevalent comorbidities50. Information on how the researchers 14 defined diagnosed type 2 DM and comorbidities was not included in the study report. Mobility impairments were determined by measures of balance and gait speed. In this older, obese cohort with type 2 DM, mobility impairments were found to be associated with low muscle power (P=0.043 to <0.0001)50. The high prevalence of obesity and OA among participants may have compromised an optimal measurement technique within the intervention groups. Although the number of comorbidities was considered, the report did not specify how these conditions were defined. An additional shortcoming was the lack of analysis or adjustment for comorbidities. Robertson et al. (1998) assessed muscle function in a cross-sectional study of patients waiting for a primary unilateral knee replacement for OA (n=26, mean age ± SD= 72 ± 8 years)43. Using a Kin-Com dynamometer, leg extensor power was found to be a repeatable measure of muscle function among men (n=13) and women (n=13) (mean difference 0.03 ± 0.24, p=. 60)43. Patients’ affected legs (Test 1=57.7 ± 31.8 W, Test 2=59.3 ± 29.9 W) had lower power than the unaffected legs (Test 1=85.0 ± 39.7W, Test 2=82.1 ± 40.7W)43. Although statistically significant (p<0.05), the lack of a comparison group consisting of participants without OA of the knee limited the study’s generalizability. Sayers and colleagues (2010, 2012) compared two studies and found that older adults with knee OA52 and community dwelling older adults without an OA diagnosis51 improved muscle performance measures in a similar manner. The primary study consisted of 38 healthy, community-dwelling older men and women without an OA diagnosis51. In a follow-up study, 33 older adults (mean age ± SD= 67.6 ± 6.8 years) with knee OA were randomized into high-speed power training (HSPT, n=12), slow-speed power training (SSPT, n=10), and control (CON, n=11) groups52. Greater improvements in peak muscle power among those with knee OA, measured by a Keiser pneumatic leg press, were reported within the HSPT group compared to 15 those in the CON group (p= 0.04)52. The intervention groups had large increases of peak power measures, though not mobility-based functional tasks52. In a review of high-speed power training, Sayers et al. (2007) concluded that chronic diseases like knee OA remain overlooked in the literature when investigating the importance of movement speed and rapid force-producing capability in older adults37. The limited amount of current literature on the relationship between OA and leg power in older adults is restricted by small sample sizes, interactions with other chronic diseases and the lack of a standard measure of leg power. Traditional leg power extension measures propose difficulties with pain and range of motion of joints. Therefore, strength measurements may not be feasible among individuals with OA. OA has been evaluated in several randomized controlled trials and is frequently included in participant characteristics. Future studies may benefit from using task-based power measurements to evaluate muscle power between older adults with and without OA and the potential correlations with mobility-based functional tasks. 3.2 DIABETES MELLITUS According to the Centers for Disease Control and Prevention, 10.9 million (26.9%) individuals in the US, age 65 years or older, have DM87. A large increase in prevalence among those 75 years or older is expected in the future2. Incidence of DM has been estimated to be 4.2/1000 according to data standardized to the 2000 US population97. Older adults and minorities are estimated to have the fastest increases in DM diagnoses, and it is estimated that diagnoses will increase by 16 165% between 2000 and 2050 in the US105. Among adults age 65 years and older, DM is the sixth leading cause of death18. Development of disability is approximately two to three times greater in diabetic older adults than those without this condition106. Physical disability often leads to additional use of health services, institutionalization, reductions in QOL, and a lowered overall health status107. Studies have established a decrease in strength and function with DM108, 109. In addition, type 2 diabetic older adults have displayed lower “muscle quality”110 and often have multiple comorbidities in old age50. Hilton and colleagues (2008) studied associations of performance and function in individuals with obesity, DM, and PN111. Differences in muscle power were reported for 6 participants (mean age ± SD= 58 ± 10 years) and their 6 age- and sex-matched controls (mean age ± SD= 58 ± 9.2 years). Increased risk of DM, CVD, disability, and mortality is associated with obesity111-114. A Biodex Multi-joint System 3 Pro isokinetic dynamometer assessed concentric isokinetic and isometric ankle plantar-flexor and ankle dorsiflexor strength and power111. The ratio of maximal plantar-flexor muscle power output to lower-extremity muscle volume was lower in the participants with obesity, DM, and PN in comparison to controls at angular velocities of 60°/s (0.133 vs. 0.0.031, P<0.05) and 120°/s (0.184 vs. 0.0.036, P<0.05)111. Calf intermuscular adipose tissue (IMAT) volumes were 2.2-fold higher in participants with obesity, DM, and PN (mean volume ± SD= 120 ± 47 cm3) in comparison to the control group (mean volume ± SD= 54 ± 41 cm3)111. Participants who were obese with chronic DM and PN had significantly weaker ankle dorsiflexors and plantar-flexor muscle power than the control group111. Ankle dorsiflexor muscle power was 83-86% lower (1.3 vs. 9.6, P<0.05 to 2.1 vs. 12.4, P<0.05), and ankle plantar-flexor muscle power was 73-77% lower (13.4 vs. 50.0, P<0.05 to 15.9 vs. 69.3, P<0.05)111. Limitations included the small sample size and cross-sectional design; 17 however, the findings revealed the extent of muscle power impairments among those with obesity, DM, and PN111. Expanding this preliminary data with prospective studies and optimal leg power measurement techniques may better determine if muscle power predicts the onset of disability in people who are obese with DM and PN110, 111. Men with type 2 DM participating in a twice weekly, whole-body progressive resistance training (PRT) program showed peak power output improvements74, 115. Ibanez et al. (2008) used the same intervention plan while comparing type 2 diabetic, older sedentary men (n=9, mean age ± SD= 66.6 ± 3.1 years) to a control group of their age-matched healthy counterparts (n=11, mean age ± SD= 64.8 ± 2.6 years)106. Post-training gains were found in leg muscle power output among control participants (323.5 ± 122.1 W vs. 394.4 ± 147.2 W, P<0.001) and diabetic participants (239.5 ± 53.9 W vs. 312.3 ± 52.8 W, P<0.01)106. However, no significant posttraining difference between the diabetic group and the non-diabetic control group was observed in the power output of leg extensor muscles at 30% of their 1-RM half-squat106. Post-training 1RM half-squat strength gains occurred among control participants (103.1 ± 25.9 kg vs. 135.0 ± 32.5 kg, p<0.001) and diabetic participants (106.3 ± 8.3 kg vs. 124.1 ± 8.0 kg, p<0.001)106. The results suggest that older type 2 diabetic men might develop fewer strength gains, but achieve similar muscle power gains with resistance training106. However, the authors theorized that increases in intensity and maximal strength targets might have been too stressful and physically exhausting for the diabetic older men106. Therefore, diabetic individuals may benefit from power training instead of maximal strength training. However, data are difficult to interpret due to the study’s small sample size. Orr et al. (2006) randomized 38 type 2 diabetic patients into a 4-month tai chi (n=17, mean age ± SD= 65.9 ± 7.4 years) and sham exercise (n=18, mean age ± SD= 64.9 ± 8.1 years) 18 controlled trial to determine associations with muscle power50. Although not statistically significant, peak muscle power was obtained with a Keiser pneumatic leg press and changed by 4.8 ± 18.1% in the tai chi group and -0.4 ± 16.7% in the sham exercise group from baseline to follow-up50. Among all participants, the most common participant comorbidities were hypertension (76%) and OA (84%)50. At baseline, a higher number of comorbidities and poorer muscle power were related to impaired balance in addition to old age, high percent body fat, poor cognition, low QOL, low exercise capacity, slow gait speed, and decreased muscle contraction velocity (p=0.043 to <0.0001)50. Existing comorbidities between the tai chi group (6.9 ± 6.7) and control group (6.1 ± 8.8) were not analyzed independently in relation to the leg power measurements50. The study concluded mobility impairments in older, obese individuals with type 2 DM are associated with low muscle power50. The high prevalence of obesity and OA among participants may be a study limitation. Comorbidities may have affected the results, but were not adjusted for in analyses. Volpato et al. (2012) performed a cross-sectional analysis of 835 community-dwelling adults age 65 years or older enrolled in the InCHIANTI population-based study62. Indicators of muscle performance, including muscle power, were assessed among 11.4% of the cohort with prevalent DM (mean age ± SD =73.9 ± 6.2), in addition to the non-diabetic (mean age ± SD =73.8 ± 6.5) participants62. Lower-extremity muscle power was measured by the Nottingham power rig and tended to be lower among participants with DM (-6.9 ± 4.2 W) in comparison to those without (65.8 ± 1.8) after adjusting for age and sex (p=0.102)62. Lower muscle power (65.8 ± 1.8 vs. -12.7 ±5.2), quality, density, and strength were found in participants with DM when the analysis was restricted to those on pharmacological therapy (p<0.05)62. A temporal or causal relationship could not be determined because of the cross-sectional and observational study 19 design62. However, the researchers suggested that clinical and biological evidence revealed potential negative effects of DM on muscle physiology and walking performance62. Small sample sizes, obesity, OA, and cross-sectional designs were obstacles to effectively assessing the relationship between DM and leg power in older adults. No studies evaluated minorities, investigated differences between men and women separately or used task-based measures to test lower-extremity leg power. However, individuals with DM appeared to have few complications with measuring leg power. Additionally, statistically significant findings of low muscle power among participants with DM were consistent throughout. Longitudinal data is needed to strengthen conclusions and determine causal relationships. 3.3 CARDIOVASCULAR DISEASE CVD is a prominent cause of disability and the leading cause of death worldwide116. CVD is responsible for one in three reported deaths in the US each year83, 116 . Classifications of the disease include myocardial infarction (MI), coronary artery disease (CAD), congestive heart failure (CHF), peripheral vascular disease (PVD), and hypertension18, 117. The Framingham Heart study reported a doubling of prevalence of chronic heart failure with each additional decade of life and a 7-10% prevalence level among persons 80 years or older18, 118, 119. Heart failure occurs among 7.8% of men and 4.5% of women age 60-79 years84. In the same age bracket, 21.1% of men and 10.6% of women have CAD84. Hypertension is a prominent risk factor of heart disease and stroke120, 121 . In the US, 72.6% of men and 71.9% of women age 60-79 years have hypertension83, and prevalence rates increase with age83. According to data from the National 20 Health and Nutrition Examination Survey (NHANES) 2005-2008, men and women have nearly equal hypertension prevalence rates83. PVD rates are similar among men and women as well, and increase drastically with age122. Approximately 13.7% of men and 15.0% of women age 70 years and older develop PVD122. Adults 65 years of age and older, in the US, account for >50% of all acute MIs and coronary bypass operations123, 124. The American Heart Association has concluded that men are more frequently hospitalized for heart disease and acute MI while women have higher hospitalization rates for CHF and stroke83. As medical advancements increase the survival rate following acute cardiovascular events, rates of individuals living with chronic CVD will increase116. Foldvari et al. (2000) used baseline data from a 1-year randomized controlled clinical trial of community-dwelling, sedentary and independent elderly women (mean age ± SD = 74.8 ± 5.0 years) with a variety of chronic medical conditions and disabilities (3.2 ± 1.9)23. They aimed to test whether peak muscle power, assessed by a Keiser pneumatic leg press, was closely associated with self-reported functional status23. Out of all physiological factors tested, including leg strength (r=0.43, p=0.0001), leg power was found to have the strongest univariate correlation to functional status (r= -.47, p<0.0001)23. Hypertension (55%), PVD (19%), and CAD (15%) were among the most common participant medical diagnoses23. The study’s relatively small sample size and homogeneous sample limited generalizability. Although it is important to acknowledge the high prevalence of CVD among women age 70 years and older, relationships with men should be assessed as well. Additional longitudinal analyses of chronic disease prevalence, CVD, and leg power measurements should be a future research direction. 21 Kuh et al. (2005) assessed data from a British cohort study (N=2956) that consisted of participants aged 53 years69. Functional leg power was measured by chair rise time. Men (11.7%) and women (12.2%) were categorized into a “disabling/life threatening conditions” health group based on a diagnosis of at least one health condition of DM, cancer, epilepsy, and/or cardiovascular problems69. Chair rise time was collected from 1332 men and 1363 women. After adjusting for height, weight, physical activity, musculoskeletal symptoms, respiratory symptoms, and social class, differences between participants in the “disabling/lifethreatening conditions” health group and chair rise times were found among men (r=-.36, p=0.020) and women (r=-.39, p=0.003)69. Overall, chair rise times were reported as slower in adults with poorer health. The effects were significant for the “disabling/life threatening conditions” health group. The investigators limited eligibility to healthy participants to prevent incomplete physical performance tasks by individuals with more functional limitations, health problems, and sedentary lifestyles. Approximately two thirds (67.0%) of participants (N=1753, ≥ 60 years age) involved in a study by Kuo et al (2006) were hypertensive as determined by a self-report of a physician’s diagnosis38. Medical histories of CVD (MI, CHF, and angina) and DM were reported. All chronic conditions were adjusted for prior to the analysis of muscle power and disability. Knee extensor force production was assessed by a Kin-Com isokinetic dynamometer. The study findings provided additional evidence of the importance of leg power impairments as a clinical indication of individuals at risk of disability38. A weakness of this study was failing to examine how these cardiovascular comorbidities affected leg power measurements. McDermott et al. (2004) sampled community-dwelling men and women age 60 years and older from two Italian cities59. Of these participants, 109 had lower extremity PVD as defined by 22 <0.90 on the ankle-brachial index (ABI)59. The researchers measured lower extremity leg power with a Nottingham power rig and examined PVD associations. Participants with PVD (an average of 83.69 watts, mean age= 78.27 years) were found to have reduced muscle power in the lower extremities in comparison to participants without PVD (an average of 103.51 watts, mean age = 73.78 years, p<0.001)59. Additionally. McDermott et al. (2008) measured knee extension power, strength, and handgrip of 424 participants with PVD (mean age ± SD =71.39 ± 7.56) and 271 participants without PVD (mean age ± SD = 74.97 ± 8.24)60. They aimed to determine associations of strength and lower extremity performance among individuals with lower ABI levels. The study was conducted with a cross-sectional design and Nottingham leg power measurements. Lower knee extension power was found to be associated with lower ABI values; however, these results were not statistically significant60. Participants with PVD had lower knee extension power than those without PVD (93.49 ± 52.73 W vs. 117.17 ± 68.6 W, p<0.001) after adjusting for age, sex, race, comorbidities, body mass index, smoking history, leg symptoms, and recruitment cohort60. Although comorbidities were adjusted for statistical analyses, the prevalence of each disease was not reported. No significant associations were found between knee extension isometric strength and ABI60. Longitudinal studies could provide further opportunity for determining associations between PVD and leg power among older adults. Saunders et al. (2008) conducted a cross-sectional, observational study using baseline data from a randomized controlled trial61. Participants were community dwelling and independently ambulatory (n=66, mean age ± SD= 72.10 ± 9.91 years) after a stroke61. The researchers aimed to determine associations of activity limitations and lower-limb explosive extensor power with a Nottingham power rig61. Cardiovascular comorbidities of ischemic heart 23 disease (n=22), left ventricular failure (n=2) and hypertension (n=31) were considered as potential confounders; however, comorbid disease(s) were not found to be predictive of lowerlimb extensor power61. Restrictive eligibility criteria and the homogeneity of the sample may have limited the ability to find an association between comorbid disease and lower limb extensor power. Limited data exists on CVD and muscle power among older adults. A majority of the studies had cross-sectional designs and limited generalizability. Restrictive eligibility criteria limited analysis between leg power and cardiovascular comorbidities. However, reliable data exists to show that PVD is associated with lower-extremity muscle power. 24 4.0 CONCLUSION Recently, muscle power (Power=Force x Velocity)22 has become a more common predictor of late-life disability and a frequent measure of physical function among older adults6, 17-19. Chronic diseases have been found to be essential underlying causes of physical disability in late life as well8-10. However, few studies have assessed the relationship between muscle power and the prevalent chronic diseases of OA, DM, and CVD. In addition to the most feasible leg power measure for older adults remaining undetermined, many questions have yet to be answered about the relationship between leg power and chronic disease in older adults. The study designs assessed in this review varied when considering the relationship between leg power and chronic disease. A large proportion of the studies used cross-sectional analyses. Although these were convenient to conduct, the investigators could not determine causal relationships. Most of the controlled trials involved randomizing participants to exercise or training programs; however, comparing participants with chronic disease to case-matched controls may give the most accurate and reliable results. Alternatively, large cohort studies of ethnically and geographically diverse older adults with thorough measurements of chronic disease may offer a higher quality design. The primary weakness among all study designs was that the main hypotheses did not directly relate to chronic disease and its relationship with lowerextremity muscle power. 25 In general, the studied populations were not representative of the general population of aging adults. Age ranges and the mean age varied greatly between studies. Most eligibility criteria required participants to be considered healthy and community dwelling. Health status was frequently determined by self-report, rather than a clinic evaluation. In addition, the majority of leg power studies exclude acute and chronic diseases. Therefore, a limited amount of studies directly compared chronic disease and leg power. Homogeneous samples were common and races were rarely specified, creating limited generalizability. Comprehensive measures of disease were weak throughout the studies. Studies involving participants with PVD did not determine inclusion based on a standard ABI level and did not specify how the disease was identified. Few DM studies ascertained disease by the standard American Diabetes Association criteria, and self-report remained the standard for CVD diagnoses. The definition of CVD differed between studies, and few directly addressed its relationship with leg power. The measures of leg power were not comprehensive, and studies rarely justified why they chose one technique over the other. With a variety of leg power measures performed throughout the various studies, it became difficult to determine which was the superior method of measurement among older adults with chronic conditions. Future research should focus on conducting larger prospective studies and determining the optimal leg power measure for adults with one or more chronic diseases. Analysis of the relationships between chronic diseases and leg power should include acute and severe conditions. 26 BIBLIOGRAPHY 1. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World Population Prospects: The 2010 Revision, 2011: Available from: http://esa.un.org/wpp/documentation/pdf/WPP2010_Highlights.pdf. 2. Centers for Disease Control and Prevention. Public health and aging: trends in aging-United States and worldwide. JAMA : the journal of the American Medical Association. 2003; 289:1371-3. 3. Drey M, Zech A, Freiberger E, Bertsch T, Uter W, Sieber CC, et al. Effects of strength training versus power training on physical performance in prefrail community-dwelling older adults. Gerontology. 2012; 58:197-204. 4. Reinhardt UE. Does the aging of the population really drive the demand for health care? Health Aff (Millwood). 2003; 22:27-39. 5. Espeland MA, Gill TM, Guralnik J, Miller ME, Fielding R, Newman AB, et al. Designing clinical trials of interventions for mobility disability: results from the lifestyle interventions and independence for elders pilot (LIFE-P) trial. The journals of gerontology Series A, Biological sciences and medical sciences. 2007; 62:1237-43. 6. Rasch EK, Hochberg MC, Magder L, Magaziner J, Altman BM. Health of communitydwelling adults with mobility limitations in the United States: prevalent health conditions. Part I. Archives of physical medicine and rehabilitation. 2008; 89:210-8. 7. Reid KF, Naumova EN, Carabello RJ, Phillips EM, Fielding RA. Lower extremity muscle mass predicts functional performance in mobility-limited elders. The journal of nutrition, health & aging. 2008; 12:493-8. 8. Evans WJ. Exercise strategies should be designed to increase muscle power. The journals of gerontology Series A, Biological sciences and medical sciences. 2000; 55:M309-10. 9. Skelton DA, Kennedy J, Rutherford OM. Explosive power and asymmetry in leg muscle function in frequent fallers and non-fallers aged over 65. Age and ageing. 2002; 31:119-25. 10. Chan BK, Marshall LM, Winters KM, Faulkner KA, Schwartz AV, Orwoll ES. Incident fall risk and physical activity and physical performance among older men: the Osteoporotic Fractures in Men Study. American journal of epidemiology. 2007; 165:696-703. 11. Bonnefoy M, Kostka T, Arsac LM, Berthouze SE, Lacour JR. Peak anaerobic power in elderly men. European journal of applied physiology and occupational physiology. 1998; 77:182-8. 12. Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age and ageing. 1994; 23:371-7. 13. Young A, Skelton DA. Applied physiology of strength and power in old age. International journal of sports medicine. 1994; 15:149-51. 27 14. Caserotti P, Aagaard P, Larsen JB, Puggaard L. Explosive heavy-resistance training in old and very old adults: changes in rapid muscle force, strength and power. Scandinavian journal of medicine & science in sports. 2008; 18:773-82. 15. Metter EJ, Conwit R, Tobin J, Fozard JL. Age-associated loss of power and strength in the upper extremities in women and men. The journals of gerontology Series A, Biological sciences and medical sciences. 1997; 52:B267-76. 16. Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. Journal of the American Geriatrics Society. 1997; 45:92-100. 17. Ho SH, Li CS, Liu CC. The influence of chronic disease, physical function, and lifestyle on health transition among the middle-aged and older persons in Taiwan. The journal of nursing research : JNR. 2009; 17:136-43. 18. Bean JF, Vora A, Frontera WR. Benefits of exercise for community-dwelling older adults. Archives of physical medicine and rehabilitation. 2004; 85:S31-42; quiz S3-4. 19. Jozsi AC, Campbell WW, Joseph L, Davey SL, Evans WJ. Changes in power with resistance training in older and younger men and women. The journals of gerontology Series A, Biological sciences and medical sciences. 1999; 54:M591-6. 20. Skelton DA, Young A, Greig CA, Malbut KE. Effects of resistance training on strength, power, and selected functional abilities of women aged 75 and older. Journal of the American Geriatrics Society. 1995; 43:1081-7. 21. Bean J, Herman S, Kiely DK, Callahan D, Mizer K, Frontera WR, et al. Weighted stair climbing in mobility-limited older people: a pilot study. Journal of the American Geriatrics Society. 2002; 50:663-70. 22. Bean JF, Kiely DK, Herman S, Leveille SG, Mizer K, Frontera WR, et al. The relationship between leg power and physical performance in mobility-limited older people. Journal of the American Geriatrics Society. 2002; 50:461-7. 23. Foldvari M, Clark M, Laviolette LC, Bernstein MA, Kaliton D, Castaneda C, et al. Association of muscle power with functional status in community-dwelling elderly women. The journals of gerontology Series A, Biological sciences and medical sciences. 2000; 55:M192-9. 24. Martin JC, Farrar RP, Wagner BM, Spirduso WW. Maximal power across the lifespan. The journals of gerontology Series A, Biological sciences and medical sciences. 2000; 55:M3116. 25. Izquierdo M, Ibanez J, Gorostiaga E, Garrues M, Zuniga A, Anton A, et al. Maximal strength and power characteristics in isometric and dynamic actions of the upper and lower extremities in middle-aged and older men. Acta physiologica Scandinavica. 1999; 167:57-68. 26. Bassey EJ, Fiatarone MA, O'Neill EF, Kelly M, Evans WJ, Lipsitz LA. Leg extensor power and functional performance in very old men and women. Clin Sci (Lond). 1992; 82:321-7. 27. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Ferrucci L. A comparison of leg power and leg strength within the InCHIANTI study: which influences mobility more? The journals of gerontology Series A, Biological sciences and medical sciences. 2003; 58:728-33. 28. Larsson L, Grimby G, Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol. 1979; 46:451-6. 29. Miszko TA, Cress ME, Slade JM, Covey CJ, Agrawal SK, Doerr CE. Effect of strength and power training on physical function in community-dwelling older adults. The journals of gerontology Series A, Biological sciences and medical sciences. 2003; 58:171-5. 30. Lexell J. Human aging, muscle mass, and fiber type composition. The journals of gerontology Series A, Biological sciences and medical sciences. 1995; 50 Spec No:11-6. 28 31. Newton RU, Hakkinen K, Hakkinen A, McCormick M, Volek J, Kraemer WJ. Mixedmethods resistance training increases power and strength of young and older men. Medicine and science in sports and exercise. 2002; 34:1367-75. 32. Strotmeyer E, Leishear K, Boudreau R, Zivkovic S, Vinik A, Schwartz A, et al., editors. Prevalent diabetes, peripheral vascular disease and cystatin-C are related to peripheral nerve declines in the oldest old adults. American Diabetes Association 70th Scientific Sessions; 2010; Orlando, FL, USA: Diabetes. 59(S1A):LB35. 33. Ward R, Caserotti P, Faulkner K, Boudreau R, Cawthon P, Newman A, et al. Peripheral nerve function and lower extremity muscle power in older men. Boston, MA, USA2011. 34. Strotmeyer ES, de Rekeneire N, Schwartz AV, Faulkner KA, Resnick HE, Goodpaster BH, et al. The relationship of reduced peripheral nerve function and diabetes with physical performance in older white and black adults: the Health, Aging, and Body Composition (Health ABC) study. Diabetes care. 2008; 31:1767-72. 35. Norris AH, Shock NW, Wagman IH. Age changes in the maximum conduction velocity of motor fibers of human ulnar nerves. J Appl Physiol. 1953; 5:589-93. 36. Wagman IH, Lesse H. Maximum conduction velocities of motor fibers of ulnar nerve in human subjects of various ages and sizes. Journal of neurophysiology. 1952; 15:235-44. 37. Sayers SP. High-speed power training: a novel approach to resistance training in older men and women. A brief review and pilot study. Journal of strength and conditioning research / National Strength & Conditioning Association. 2007; 21:518-26. 38. Kuo HK, Leveille SG, Yen CJ, Chai HM, Chang CH, Yeh YC, et al. Exploring how peak leg power and usual gait speed are linked to late-life disability: data from the National Health and Nutrition Examination Survey (NHANES), 1999-2002. American journal of physical medicine & rehabilitation / Association of Academic Physiatrists. 2006; 85:650-8. 39. Caserotti P, Aagaard P, Simonsen EB, Puggaard L. Contraction-specific differences in maximal muscle power during stretch-shortening cycle movements in elderly males and females. European journal of applied physiology. 2001; 84:206-12. 40. Sayers SP, Bean J, Cuoco A, LeBrasseur NK, Jette A, Fielding RA. Changes in function and disability after resistance training: does velocity matter?: a pilot study. American journal of physical medicine & rehabilitation / Association of Academic Physiatrists. 2003; 82:605-13. 41. Lindemann U, Claus H, Stuber M, Augat P, Muche R, Nikolaus T, et al. Measuring power during the sit-to-stand transfer. European journal of applied physiology. 2003; 89:466-70. 42. Bean JF, Herman S, Kiely DK, Frey IC, Leveille SG, Fielding RA, et al. Increased Velocity Exercise Specific to Task (InVEST) training: a pilot study exploring effects on leg power, balance, and mobility in community-dwelling older women. Journal of the American Geriatrics Society. 2004; 52:799-804. 43. Robertson S, Frost H, Doll H, O'Connor JJ. Leg extensor power and quadriceps strength: an assessment of repeatability in patients with osteoarthritic knees. Clinical rehabilitation. 1998; 12:120-6. 44. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. The New England journal of medicine. 1994; 330:1769-75. 45. de Vos NJ, Singh NA, Ross DA, Stavrinos TM, Orr R, Fiatarone Singh MA. Optimal load for increasing muscle power during explosive resistance training in older adults. The journals of gerontology Series A, Biological sciences and medical sciences. 2005; 60:638-47. 29 46. Fielding RA, LeBrasseur NK, Cuoco A, Bean J, Mizer K, Fiatarone Singh MA. Highvelocity resistance training increases skeletal muscle peak power in older women. Journal of the American Geriatrics Society. 2002; 50:655-62. 47. Thomas M, Fiatarone MA, Fielding RA. Leg power in young women: relationship to body composition, strength, and function. Medicine and science in sports and exercise. 1996; 28:1321-6. 48. Cuoco A, Callahan DM, Sayers S, Frontera WR, Bean J, Fielding RA. Impact of muscle power and force on gait speed in disabled older men and women. The journals of gerontology Series A, Biological sciences and medical sciences. 2004; 59:1200-6. 49. Cohn B. FITNESS; A power move for strength training; The high-velocity weightlifting already used by athletes may prove beneficial for average gym-goers. Los Angeles Times. 2008 Apr 7, 2008;Sect. F.10. 50. Orr R, Tsang T, Lam P, Comino E, Singh MF. Mobility impairment in type 2 diabetes: association with muscle power and effect of Tai Chi intervention. Diabetes care. 2006; 29:21202. 51. Sayers SP, Gibson K. A comparison of high-speed power training and traditional slowspeed resistance training in older men and women. Journal of strength and conditioning research / National Strength & Conditioning Association. 2010; 24:3369-80. 52. Sayers SP, Gibson K, Cook CR. Effect of high-speed power training on muscle performance, function, and pain in older adults with knee osteoarthritis: a pilot investigation. Arthritis care & research. 2012; 64:46-53. 53. Bassey EJ, Short AH. A new method for measuring power output in a single leg extension: feasibility, reliability and validity. European journal of applied physiology and occupational physiology. 1990; 60:385-90. 54. Blackwell T, Cawthon PM, Marshall LM, Brand R. Consistency of leg extension power assessments in older men: the Osteoporotic Fractures in Men (MrOS) Study. American journal of physical medicine & rehabilitation / Association of Academic Physiatrists. 2009; 88:934-40. 55. The University of Nottingham, Medical Engineering Unit. Leg Extensor Power Rig. The University of Nottingham [cited 2013]; Available from: http://www.nottingham.ac.uk/biomedsci/documents/meu/legrig.pdf. 56. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Ageassociated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003; 95:1851-60. 57. Bassey EJ. Measurement of muscle strength and power. Muscle & nerve Supplement. 1997; 5:S44-6. 58. Pearson MB, Bassey EJ, Bendall MJ. Muscle strength and anthropometric indices in elderly men and women. Age and ageing. 1985; 14:49-54. 59. McDermott MM, Guralnik JM, Albay M, Bandinelli S, Miniati B, Ferrucci L. Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI Study. Journal of the American Geriatrics Society. 2004; 52:405-10. 60. McDermott MM, Tian L, Ferrucci L, Liu K, Guralnik JM, Liao Y, et al. Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. Journal of the American Geriatrics Society. 2008; 56:724-9. 30 61. Saunders DH, Greig CA, Young A, Mead GE. Association of activity limitations and lower-limb explosive extensor power in ambulatory people with stroke. Archives of physical medicine and rehabilitation. 2008; 89:677-83. 62. Volpato S, Bianchi L, Lauretani F, Lauretani F, Bandinelli S, Guralnik JM, et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes care. 2012; 35:1672-9. 63. Vannozzi G, Pecoraro F, Caserotti P, Cappozzo A. A neurofuzzy inference system based on biomechanical features for the evaluation of the effects of physical training. Computer methods in biomechanics and biomedical engineering. 2008; 11:11-7. 64. Wretenberg P, Arborelius UP. Power and work produced in different leg muscle groups when rising from a chair. European journal of applied physiology and occupational physiology. 1994; 68:413-7. 65. Lindemann U, Muche R, Stuber M, Zijlstra W, Hauer K, Becker C. Coordination of strength exertion during the chair-rise movement in very old people. The journals of gerontology Series A, Biological sciences and medical sciences. 2007; 62:636-40. 66. Zech A, Steib S, Sportwiss D, Freiberger E, Pfeifer K. Functional muscle power testing in young, middle-aged, and community-dwelling nonfrail and prefrail older adults. Archives of physical medicine and rehabilitation. 2011; 92:967-71. 67. Chou SW, Wong AM, Leong CP, Hong WS, Tang FT, Lin TH. Postural control during sit-to stand and gait in stroke patients. American journal of physical medicine & rehabilitation / Association of Academic Physiatrists. 2003; 82:42-7. 68. Alexander NB, Galecki AT, Grenier ML, Nyquist LV, Hofmeyer MR, Grunawalt JC, et al. Task-specific resistance training to improve the ability of activities of daily living-impaired older adults to rise from a bed and from a chair. Journal of the American Geriatrics Society. 2001; 49:1418-27. 69. Kuh D, Bassey EJ, Butterworth S, Hardy R, Wadsworth ME. Grip strength, postural control, and functional leg power in a representative cohort of British men and women: associations with physical activity, health status, and socioeconomic conditions. The journals of gerontology Series A, Biological sciences and medical sciences. 2005; 60:224-31. 70. Csuka M, McCarty DJ. Simple method for measurement of lower extremity muscle strength. The American journal of medicine. 1985; 78:77-81. 71. Lord SR, Murray SM, Chapman K, Munro B, Tiedemann A. Sit-to-stand performance depends on sensation, speed, balance, and psychological status in addition to strength in older people. The journals of gerontology Series A, Biological sciences and medical sciences. 2002; 57:M539-43. 72. De Vito G, Bernardi M, Forte R, Pulejo C, Macaluso A, Figura F. Determinants of maximal instantaneous muscle power in women aged 50-75 years. European journal of applied physiology and occupational physiology. 1998; 78:59-64. 73. Holsgaard Larsen A, Caserotti P, Puggaard L, Aagaard P. Reproducibility and relationship of single-joint strength vs multi-joint strength and power in aging individuals. Scandinavian journal of medicine & science in sports. 2007; 17:43-53. 74. Izquierdo M, Hakkinen K, Ibanez J, Garrues M, Anton A, Zuniga A, et al. Effects of strength training on muscle power and serum hormones in middle-aged and older men. J Appl Physiol. 2001; 90:1497-507. 75. Runge M, Rittweger J, Russo CR, Schiessl H, Felsenberg D. Is muscle power output a key factor in the age-related decline in physical performance? A comparison of muscle cross 31 section, chair-rising test and jumping power. Clinical physiology and functional imaging. 2004; 24:335-40. 76. Rittweger J, Schiessl H, Felsenberg D, Runge M. Reproducibility of the jumping mechanography as a test of mechanical power output in physically competent adult and elderly subjects. Journal of the American Geriatrics Society. 2004; 52:128-31. 77. Bosco C, Komi PV. Influence of aging on the mechanical behavior of leg extensor muscles. European journal of applied physiology and occupational physiology. 1980; 45:209-19. 78. Paasuke M, Ereline J, Gapeyeva H. Age-related differences in knee extension rate of isometric force development and vertical jumping performance in women. The Journal of sports medicine and physical fitness. 2003; 43:453-8. 79. Haguenauer M, Legreneur P, Monteil KM. Vertical jumping reorganization with aging: a kinematic comparison between young and elderly men. Journal of applied biomechanics. 2005; 21:236-46. 80. Institute of Medicine, Commitee On A National Agenda for Prevention of Disabilities. Disability in America: Toward a National Agenda for Prevention. Washington, DC: Institute of Medicine, National Academy Press,1991. 81. In: Field MJ, Jette AM, editors. The Future of Disability in America. Washington (DC)2007. 82. United Nations. Report of the Second World Assembly on Aging. Madrid (Spain): United Nations; April 8-12, 2002. 83. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011; 123:e18-e209. 84. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013; 127:e6-e245. 85. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clinical orthopaedics and related research. 2004:S6-15. 86. Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. The Journal of rheumatology. 2006; 33:2271-9. 87. Centers for Disease Control and Prevention. 2011 National Diabetes Fact Sheet. 2011 [updated May 23, 2011; cited 2013 March 7]; Available from: http://www.cdc.gov/diabetes/pubs/estimates11.htm. 88. Centers for Disease Control and Prevention and The Merck Company Foundation. The State of Aging and Health in America 2007. Whitehouse Station, NJ: The Merck Company Foundation; 2007. 89. Hoffman C, Rice D, Sung HY. Persons with chronic conditions. Their prevalence and costs. JAMA : the journal of the American Medical Association. 1996; 276:1473-9. 90. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. The journals of gerontology Series A, Biological sciences and medical sciences. 2001; 56:M146-56. 91. Desai MM, Zhang P, Hennessy CH. Surveillance for morbidity and mortality among older adults--United States, 1995-1996. MMWR CDC surveillance summaries : Morbidity and mortality weekly report CDC surveillance summaries / Centers for Disease Control. 1999; 48:725. 32 92. Trends in aging--United States and worldwide. MMWR Morbidity and mortality weekly report. 2003; 52:101-4, 6. 93. Exercise prescription for older adults with osteoarthritis pain: consensus practice recommendations. A supplement to the AGS Clinical Practice Guidelines on the management of chronic pain in older adults. Journal of the American Geriatrics Society. 2001; 49:808-23. 94. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention. 2005. 95. Andersen H, Gadeberg PC, Brock B, Jakobsen J. Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia. 1997; 40:1062-9. 96. Dieppe P. Strategies for the prevention of osteoarthritis. International journal of tissue reactions. 1993; 15:93-7. 97. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA : the journal of the American Medical Association. 2003; 290:1884-90. 98. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003; 326:1419. 99. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis and rheumatism. 2006; 54:226-9. 100. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis and rheumatism. 1987; 30:914-8. 101. Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis and rheumatism. 1995; 38:1134-41. 102. Fransen M, McConnell S, Bell M. Therapeutic exercise for people with osteoarthritis of the hip or knee. A systematic review. The Journal of rheumatology. 2002; 29:1737-45. 103. Reid KF, Fielding RA. Skeletal muscle power: a critical determinant of physical functioning in older adults. Exercise and sport sciences reviews. 2012; 40:4-12. 104. Clark DJ, Patten C, Reid KF, Carabello RJ, Phillips EM, Fielding RA. Impaired voluntary neuromuscular activation limits muscle power in mobility-limited older adults. The journals of gerontology Series A, Biological sciences and medical sciences. 2010; 65:495-502. 105. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes care. 2001; 24:1936-40. 106. Ibanez J, Gorostiaga EM, Alonso AM, Forga L, Arguelles I, Larrion JL, et al. Lower muscle strength gains in older men with type 2 diabetes after resistance training. Journal of diabetes and its complications. 2008; 22:112-8. 107. Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM, et al. Diabetes and physical disability among older U.S. adults. Diabetes care. 2000; 23:1272-7. 108. Anderson KN, Baban D, Oliver PL, Potter A, Davies KE. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit. Neuromuscular disorders : NMD. 2004; 14:711-22. 109. Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes care. 2007; 30:1507-12. 33 110. Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006; 55:1813-8. 111. Hilton TN, Tuttle LJ, Bohnert KL, Mueller MJ, Sinacore DR. Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Physical therapy. 2008; 88:1336-44. 112. Alley DE, Chang VW. The changing relationship of obesity and disability, 1988-2004. JAMA : the journal of the American Medical Association. 2007; 298:2020-7. 113. Katzmarzyk PT, Janssen I, Ardern CI. Physical inactivity, excess adiposity and premature mortality. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2003; 4:257-90. 114. Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical therapy. 2008; 88:1322-35. 115. Ibanez J, Izquierdo M, Arguelles I, Forga L, Larrion JL, Garcia-Unciti M, et al. Twiceweekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes care. 2005; 28:662-7. 116. McDermott MM. The international pandemic of chronic cardiovascular disease. JAMA : the journal of the American Medical Association. 2007; 297:1253-5. 117. Kramarow E, Lentzner H, Rooks R, Weeks J, Saydah S. Health and Aging Chartbook. Health, United States, 1999. Hyattsville, Maryland: National Center for Health Statistics. 1999. 118. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. Journal of the American College of Cardiology. 1993; 22:6A-13A. 119. Witham MD, Struthers AD, McMurdo ME. Exercise training as a therapy for chronic heart failure: can older people benefit? Journal of the American Geriatrics Society. 2003; 51:699709. 120. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004; 44:398-404. 121. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. The American journal of cardiology. 2003; 91:9G-14G. 122. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110:738-43. 123. American Heart Association. 2000 Heart and stroke statistical update. Dallas, Texas: American Heart Association. 1999. 124. Alexander KP, Peterson ED. Coronary artery bypass grafting in the elderly. American heart journal. 1997; 134:856-64. 34